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Abstract. National Health Insurance, a public health insurance currently used in Indonesia, is created 
with the aim of effective and efficient quality health services for the community and providers of health 
facilities, but on the one hand it still has the potential to cause real costs for hospitals as found in the 
case of hospitalization of patients with dengue fever. Basically, dengue fever is included in the category 
of tropical infectious diseases and in its handling falls into the non-surgical category, but the reality in 
the case of this disease provides a significant negative difference for the hospital, in contrast to previous 
studies which state that special cases surgery gives a lot of real costs to hospitals. Details of treatment 
costs that can be concluded from patients admitted to the hospital until the patient returns home with 
the approval of the doctor in cases of dengue fever include: (1) inpatient room, (2) examination of 
emergency room / outpatient clinic, (3) general practitioner visits, (4 ) specialist visits, (5) drugs, (6) 
injection drugs, (7) intravenous fluids, (8) use of ingredients, (9) room actions, (10) laboratory 
examinations, and (11) administration. The research method used is descriptive qualitative. The data 
used came from claims files and medical records of JKN-BPJS dengue fever patients in Sinar Kasih 
Hospital Purwokerto for the period of January 1, 2019 until March 30, 2019. The sampling technique 
uses total sampling, with 60 subjects after going through the exclusion process. All data were observed 
and recorded on the observation sheet, then analysed data using descriptive statistical analysis. The 
results of the study explain that the biggest cause of over cost in this case is hospitalization and 
laboratory examination.  
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1. INTRODUCTION 
 
In the National Health Insurance in Indonesia it called Jaminan Kesehatan Nasional 
(JKN), the pattern of payments to advanced health facilities in Indonesia is regulated by 
INA-CBGs (Indonesian Case Based Groups), which is a system of providing health 
services based on group diagnosis of disease as cost control without overriding health 
services quality, so that the health services provided are effective and efficient (Annavi, 
2011) and the Health Social Security Organizing Agency (BPJS) is a public legal entity 
formed to organize Health Insurance programs (Regulation of the Minister of Health of 
the Republic of Indonesia Number 54, 2014). 
 
It has been observed that INA-CBGs rates are still likely to cause harm to hospitals 
(Rejeki & Nurwahyuni, 2017) (Putra et.al, 2014), which is a significant difference between 
the service rates obtained by the Hospital with the INA-CBGs rates obtained by the 
Hospital through BPJS where rates issued by hospitals in some cases of disease (surgery) 
are greater than the rates of INA-CBGs. According to interviews conducted by researchers 
with BPJS officers in Sinar Kasih Purwokerto Hospital, one of the diseases that has the 
potential to cause harm to hospitals is dengue fever. This mainly arises in cases of dengue 
fever as the primary diagnosis, and does not apply if dengue fever is listed as a secondary 
diagnosis and there is another bacterial infection as the main diagnosis where the INA-
CBG rates will be greater than the real costs of the hospital. Dengue fever is included in 
the category of tropical infectious diseases and in its treatment falls into the non-surgical 
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category, but the reality in the case of this disease provides a significant negative 
difference for hospitals. According to data (Health Office, 2018) cases of dengue fever are 
found to occur most frequently from January to April. Below is a table that shows the 
number of hospitalized cases of dengue fever patients during the period January to March 
in 2018 and 2019. During the process of recording the data, it is also known that the 
majority of patients are class 3 JKN-BPJS users. This can increase the negative difference 
received by the hospital (Regulation of the Minister of Health of the Republic of Indonesia 
Number 69, 2013). Data for April 2019 cannot be included, because it is still in the process 
of data entry, so to equalize the data for 2018 data is also calculated until March. 
Table 1.  Dengue Fever Case Data, INA-CBGs and Hospital Rates. 
Tahun Jumlah Kasus 
(Penderita) 
Tarif INA-CBGs 
(Rupiah) 
Tarif Rumah Sakit 
(Rupiah) 
2018 17 21.138.600 37.331.786 
2019 255 312.146.200 527.873.807 
Source: BPJS Claims Data of Sinar Kasih Hospital Purwokerto 
Getting the best quality at the lowest cost - the main goal is in all aspects of the business 
sector even in the field of health services (Porter, 2010). It was stated (Porter, 2009) that 
there is a unity of values which, if resolved properly, is capable of providing overall benefits, 
covering all stakeholders in health services, namely patients, health care providers, and 
payers. At present, hospitals have become an industry that not only works for public health 
services but also tries to take advantage of it financially (Tanner et.al, 2007). One approach 
that can be done is to apply the cost of quality in the health sector. There is research on the 
cost of quality in the health sector in hospitals in the field of surgical services (Medbery, 
2014) and in cancer treatment (Mariotto, 2011), but research on the cost of quality in 
hospitals regarding denque disease is still not found, even though dengue disease is still 
found quite a lot in Indonesia (WHO, 2012). 
The concept of the cost of quality that can be applied in hospitals is mainly to direct the cost 
of failure (internal failure and external failure) to a minimum (Campanella, 1990). The cost 
of failure here can be assumed as the cost of care incurred by the hospital as long as the 
patient is hospitalized, where the emergence of over cost is known after the patient has 
finished treatment. The detailed maintenance costs that can be concluded from patients 
admitted to the hospital until the patient returns home with the approval of the doctor in 
Sinar Kasih Purwokerto Hospital include: (1) inpatient room, (2) examination of emergency 
room / polyclinic, (3) general practitioner vision, (4) visite specialist, (5) drugs, (6) injection 
drugs, (7) intravenous fluids, (8) use of ingredients, (9) room actions, (10) laboratory 
examinations, and (11) administration. Based on these data, it is then searched for any 
factors in the details of the cost of care which are the biggest potential problems causing loss 
in hospitals in hospitalized cases of dengue fever with JKN-BPJS, which is expected to bring 
alternative solutions. 
2. THEORITICAL FRAMEWORK 
2.1. Cost of Quality (CoQ) Concept 
 Cost of quality is defined as the difference that arises between the current costs of providing 
a product or service and the costs incurred in the event that there is no error (H.R. Ali, 2015). 
Cost of quality is not only useful in aspects of the business field (Harrington, 1987) but also 
in the health sector (Wei, 2015) (Sabharwhal, 2016). COQ is categorized into 4 categories: 
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prevention (P), appraisal (A), internal failure (IF), and external failure (EF). Prevention and 
appraisal cost represent control costs, while internal and external failure costs reflect 
consequential costs or failures. The aim of the COQ program is to develop strategies to 
facilitate continuous improvement efforts. The more minimal COQ is the better, this is 
realized subject to the constraints imposed by company policies, customer requirements, and 
process capabilities. In doing the strategy (Campanella, 1990) consists of four steps: 1) 
carrying out a direct attack on the cost of failure (IF and EF) in an effort to direct them to 
zero results, 2) invest in appropriate prevention activities to produce improvements, 3) 
reduce the cost of assessment in accordance with the results achieved, and 4) continue to 
evaluate and direct prevention efforts to get further improvements. 
3. RESEARCH METHOD 
This is descriptive qualitative research. Data comes from various sources including claim 
files and medical records of JKN-BPJS dengue fever patients in Sinar Kasih Hospital 
Purwokerto for the period of January 1, 2019 until March 31, 2019, with a primary diagnosis 
of dengue fever or dengue haemorrhagic fever, no secondary diagnosis, INA code -CBGs are 
A-4-13-I, patients are class-3 BPJS insurance users, use facilities according to their class, 
and return status is with the doctor's approval or healed. The sampling technique used total 
sampling and the research subjects after going through the exclusion process were 60 files. 
All data were observed and recorded on the observation sheet. Data analysis used descriptive 
statistical analysis. 
4. RESULT AND DISCUSSION 
4.1 Result  
As many as 60 files of patients with dengue fever have been observed in the details of care 
costs, with variables namely inpatient room, ED examination / polyclinic, general 
practitioner visits, specialist doctors visits, drugs, injection drugs, intravenous fluids, used 
of materials, room actions, laboratory tests and administration. It was found that the first 
biggest cost came from the inpatient room / ruang rawat (31%), the second largest cost came 
from laboratory examinations / laboratorium (25%). The characteristics of detailed 
maintenance costs are in diagram 1. 
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Diagram 1. Observed cost characteristics 
 
 
Diagram 2. Average cost per person 
 
Cost of Observation (Rupiah) 
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 Mean Standard Deviation Median 
Inpatient room 526,879.70 181,992.97 450,000 
ER/ Outpatient clinic 33,293.23 9,384.69 30,000 
General practioner visits 23,436.09 20,870.58 15,000 
Specialist visits 175,015.04 56,186.65 153,000 
Drugs 25,887.60 23,701.27 17,568 
Injenction drugs 52,136.71 58,438.94 25,500 
Intravenous fluids 112,043.23 44,756.16 112,000 
Used of materials 178,259.56 181,384.20 158,500 
Room actions 94,030.08 39,286.76 91,500 
Laboratory tests 424,289.47 212,193.45 419,000 
Administration 70,000.00 5,146.02 70,000 
Table 1. Cost of observation (Rupiah) 
4.1. Statistical Process Control (SPC) Analysis 
Of the two causes of overcost SPC analysis was then carried out. SPC is a technique that 
enables quality controllers to monitor, analyze, predict, control, and improve production 
processes through control charts. Control charts are a tool in analyzing variations of the 
production process. Usually control charts plots consist of lines showing Upper Control Limit 
(UCL), Center Line (CL), Lower Control Limit (LCL), and sample mean. The benefit of using 
the control line in SPC is to identify symptoms of deviation from a process. 
  CL   = Deviation standart 
UCL = Means + (3 x CL) 
LCL = Means – (3 x CL) 
The control line in the control chart is an effective tool for detecting specific causes of 
variation. If there are points that are outside the control line, it will be indicated that the 
process is out of control and corrective action must be taken. 
At this time the X bar used is S Chart. Xbar - s Chart is a control map for controlling processes 
based on Average (X-bar) and Standard Deviation (s). Xbar-s Chart is used if the sample size 
collected is more than 5 (n> 5) in each set of data samples, the ideal number of sample sets 
is 20-25 sets of samples. 
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Diagram 3. Trearment room S-Chart; UCL = Upper Control Limit; LCL = Lower control limit 
 
 
Diagram 4. S-Chart laboratorium; UCL = Upper Control Limit; LCL = Lower control limit 
 
 
Diagram 5. The problem of funding in the hospital for dengue fever 
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Pareto diagrams are bar graphs that show problems based on the order of the number of 
events. The sequence starts from the number of problems that occur the most until the least 
occurs. In the Graph, it is indicated by the highest graph bar (far left) to the lowest graph 
(far right). In its application, the Pareto Diagram is very useful in determining and 
identifying priority issues to be resolved. The most frequent and frequent problems are our 
top priority for taking action. The Inpatient room is the most crucial variable to overcome. 
 
4.2 Discussion 
From diagram 1 it is known that the first largest cost comes from the care room, the second 
largest cost comes from laboratory examinations. Both of these are closely related to each 
other. The care rooms in this case are related to length of stay (LOS). The longer the LOS the 
more costs incurred. Laboratory tests in this case blood tests need to be done every day in 
patients with dengue fever with low platelet levels (less than 150,000 mm) aiming to observe 
the emergence of complications of this disease. Hematocrit, albumin, liver transaminase, 
platelet count, and sodium concentration are laboratory parameters that are routinely 
examined in the management of dengue fever patients as recommended by WHO (WHO, 
2011). 
In this study, the subjects of this study were performed on patients with uncomplicated 
dengue fever. This is because, in patients with dengue fever accompanied by complications 
and / or accompanied by a secondary diagnosis as a companion of the disease it can actually 
increase BPJS claim rates (Regulation of the Minister of Health of the Republic of Indonesia 
Number 69, 2013), so that the rates obtained by hospitals can be equivalent or even more. 
The increase in service rates is also influenced by the length of stay in hospitals. The length 
of stay recommended by WHO for dengue patients is 3 to 5 days. Patients are usually treated 
during the 3rd day of fever, where the critical phase of dengue disease begins. The critical 
phase usually occurs on the 3rd to 7th day which is marked by a decrease in body temperature 
accompanied by an increase in capillary permeability and the emergence of plasma leakage 
or a decrease in platelet and leukocyte counts, usually lasting 24-48 hours, shock can occur 
in this critical phase (Fig. 1). In conditions where the critical phase has passed the patient 
can be discharged, which is usually characterized by an increase in platelets, the patient's 
general condition improves, appetite is restored and hemodynamically stable (WHO, 2009). 
 
  
Figure 1. The course of dengue illness (WHO, 2009) 
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In length of stay conditions as shown in diagram 2, it shows that there are still many costs 
that exceed the ULC. ULC applied for Rp. 500,000 and LLC for Rp. 300,000, which was based 
on the cost of the care room per day for grade 3, which was Rp. 100,000, according to the 
length of stay that should be applied according to WHO on uncomplicated dengue fever. 
Patients with dengue infection who must be hospitalized are as follows. When found danger 
signs, complaints, and signs of hypertension, bleeding, organ disorders (kidney, liver, heart, 
and neurologic), the increase in laboratory results in the form of hematocrit on laboratory re-
examination, pleural effusion, ascites, comorbidity (pregnancy, diabetes mellitus, 
hypertension) , certain social conditions (living alone, far from health facilities, and difficult 
transportation) (WHO, 2009). In conditions that occur at the place where the research is 
carried out, there are still many patients who should not require hospitalization but are still 
being treated, besides that there are still many patients with long fever 2 days with positive 
dengue results hospitalization has been done, so this causes an increase in the number of 
treatments dengue fever patients and length of hospital stay. Several studies have shown 
that the length of patient care to hospital rates is statistically significant showing a strong 
positive correlation (Puspandari et al, 2015). 
Duration of treatment includes aspects of assessing whether the hospital is efficient or not. 
Some diseases that require longer days of treatment include diabetes mellitus, cancer, lung 
disease, heart disease, stroke and psychiatric illness (Cook et al, 2009). Whereas according 
to other studies, several things that affect the length of treatment days are the age and 
condition of the patient to the disease (Agboadoa et al, 2016). 
The length of stay is related to the increase in hospital rates because the health services 
provided are also more numerous. In fact, it could actually be in vain. This raises 
inefficiencies in the allocation of funds and resources. Hospitals are expected to increase the 
efficiency and effectiveness of costs to increase the allocation of health services and reduce 
the length of treatment. In relation to the capacity of the number of beds, a lot of evidence 
shows that the increasing number of hospitals actually raises occupancy rates, resulting in 
too many empty beds in hospitals can cause inefficient resources (Chang and Lan, 2010).  
 
5. CONCLUSION 
Rates issued by hospitals are higher than the rates obtained through INA-CBGs in patients 
with dengue fever. Factors that are positively related to hospital rates and statistically 
significant are care rooms related to length of stay and laboratory examinations. 
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